ASX 200 Posts Third Week of Gains, Hit’s Record High Into Weekend – Daily Roundup

Th ASX 200 closed at an all-time high of 9,198.60 points ahead of the weekend, capping a strong week that pushed year-to-date gains to 5.39% as investors digested a mixed bag of corporate earnings that saw a broad based move to the upside, financials aside.

Daily Roundup – Leaders and Laggards

At the sector level, Materials led the charge with a 1% gain, reflecting strength in mining and rare earths companies. Energy added 0.94%, supported by stable commodity prices, while Industrials contributed with a 0.64% gain. The ASX200 Financials index bucked the trend, slipping 0.24% as markets rotate seemingly after having earlier rewarded the big four on earnings.

Block Inc (ASX: XYZ) dominated the leader board with a spectacular 27.83% surge to $94.15, while the rare earths sector rallied strongly with Lynas Rare Earths Ltd (ASX: LYC) climbing 10.09% to $18.98 and Iluka Resources Ltd (ASX: ILU) advancing 9.05% to $6.75.

Block Inc’s extraordinary gain followed the announcement of a 24% increase in gross profit to US$2.87 billion, coupled with a significant workforce reduction of nearly 6,000 positions. The dual strategy of revenue growth and cost reduction resonated strongly with markets, which interpreted the restructuring as a clear path toward improved profitability and operational efficiency.

The rare earths sector benefited from renewed global demand dynamics and strategic positioning within critical minerals supply chains. Lynas Rare Earths and Iluka Resources both capitalized on favorable market conditions and advancing project developments in rare earths processing, a sector increasingly viewed as strategically important amid ongoing supply chain diversification efforts.

On the downside, retail heavyweight Harvey Norman Holdings Ltd (ASX: HVN) tumbled 9.01% to $5.76 following earnings, while Coles Group Ltd (ASX: COL) shed 7.35% to $20.56 despite reporting what appeared to be solid earnings. Mesoblast Ltd (ASX: MSB) fell 7.44% to $2.24 as markets focused on the company’s substantial losses rather than revenue growth.

Coles Group’s 7.35% decline presented a question, as the supermarket giant reported a 12.5% increase in underlying profit to $676 million. Markets appeared concerned about margin pressures and intensifying competition in the retail grocery sector, overshadowing the headline profit figure. The reaction suggests investors are increasingly focused on forward-looking metrics rather than historical performance.

Mesoblast’s 7.44% fall came despite the biotechnology company reporting significant revenue increases from its cell therapy products. However, the company’s loss after tax of US$102.1 million raised questions about the pathway to profitability, highlighting the ongoing tension between revenue growth and bottom-line performance in the biotech sector.

Outlook

The ASX 200’s record close at 9,198.60 points represents a significant psychological milestone, though the 5.39% year-to-date gain suggests the rally has been measured, with selective rotation. Bulls will be hoping that the index has established a new support level around 9,100 points, though earnings will be critical in determining whether the rally can extend further or if profit-taking emerges at these elevated levels.

The contrasting fortunes of companies like Coles and Mesoblast highlight the market’s increasingly discriminating approach to valuation, where strong headline numbers alone are insufficient without compelling forward guidance and margin protection. This selectivity may persist as markets navigate concerns about consumer spending, input costs, and the broader economic outlook.

Friday’s record close capped a strong week that propelled the ASX 200 to new heights, though the index’s ability to build on this record will likely depend on whether the current earnings season can validate the optimism embedded in current valuations, or whether profit-taking emerges if companies struggle to meet elevated expectations. The third positive week in a row for Aussie markets will be well received, with eyes already shifting to what comes next.